Clinical Trial Update: A Pilot Trial of Ranolazine to Treat Patients With Dilated Cardiomyopathy [Phase 2]

View source ↗

Summary

Phase 2 pilot trial evaluating ranolazine for dilated cardiomyopathy has completed enrollment.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Dilated Cardiomyopathy

Drugs mentioned

• Ranolazine (ranolazine)

Snippet

Sponsor: University Medical Centre Ljubljana | Conditions: Dilated Cardiomyopathy | Phase 2 | Status: COMPLETED